Home > Press Releases > AI in Genomics Market

AI in Genomics Market Likely to Surpass USD 6.5 Billion by 2035

Report Code: HC-58957  |  Published in: Jul 2026, By MarketGenics  |  Number of pages: 356
Get PDF
Buy

Global AI in Genomics Market Forecast 2035:

According to the report, the global AI in genomics market is likely to grow from USD 0.6 Billion in 2025 to USD 6.5 Billion in 2035 at a highest CAGR of 27.8% during the time period. The AI in genomics market is showing strong growth, with organizations increasingly relying on artificial intelligence to extract actionable insights from genomic information and drive personalized healthcare solutions. next-generation sequencing (NGS), precision medicine efforts, and population-scale genomic projects are producing enormous amounts of data, which needs to be analyzed with AI to interpret rapidly, prioritize the variants, and identify biomarkers.

However, the accuracy of genomic interpretation is constantly improving, the analysis time is shorter, and the complexity of operations is decreasing with the continuous development of machine learning, generative AI and cloud-based bioinformatics platforms. The expansion of the market is further fueled by the growing investments in AI-driven drug discovery, companion diagnostics, rare disease research and integration of multi-omics. Global healthcare systems are undergoing greater innovation, improved diagnostic efficiency, and new personalized treatment strategies with strategic partnerships between genomics technology providers, biotechnology companies, and healthcare institutions.

The use of AI in genomics is spearheading the advancement of precision medicine, the discovery of more effective drugs, and also driving sustainable growth in the global market for AI in genomics.AI in genomics is helping to rapidly propel the field of precision medicine, drug discovery success, and sustainable growth of the global market.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global AI in Genomics Market”

AI is becoming an increasingly vital tool in the search for rare genetic disorders by quickly analysing genetic variants, linking genotype-phenotype relationships and prioritising disease causing mutations. The increased adoption of AI-powered clinical genomics platforms strengthens their ability to cut down on diagnostic delays, enhance accuracy of interpretation and facilitate individualized treatment planning, among other areas.

The successful implementation of AI in genomics will need a combination of multidisciplinary skills, including genomics, bioinformatics, machine learning, and clinical interpretation. The scarcity of professionals who have the dual skill sets of biology and AI poses implementation issues, delays to algorithm validation, and limits the use of sophisticated genomic analytics, especially in emerging healthcare markets.

The emergence of federated learning is opening up new possibilities for the development of AI systems, allowing healthcare institutions and research centers to jointly create models without sharing sensitive genetic information. This privacy-preserving method enables large-scale genomic studies, boosts the accuracy of AI models with a variety of data, improves regulatory standards, and drives innovation in precision medicine without compromising patient privacy.

Regional Analysis of Global AI in Genomics Market

  • North America is experiencing the highest demand for AI in genomics as genomic information is widely used in oncology, rare disease diagnosis, and companion diagnostics in clinical settings. The region is home to the majority of AI firms in the world, as well as a highly developed ecosystem for high-performance computing and commercialization of precision medicine, with a wealth of genomic databases supporting AI-driven research.
  • The region of Asia Pacific is expected to grow at a fast pace, owing to increasing investments in the national genome sequencing programs and updating of healthcare research infrastructure. Governments in the region are investing more in genomic medicine, AI research, and biotechnology development to help better diagnose diseases and to implement personalised medicine in the treatment of large and diverse populations.
  • Europe is showing strong growth with a focus on population-scale genomics programs and collaborative biomedical research. Regional programmes focused on precision medicine, rare disease research and genomic data sharing are driving the adoption of AI in healthcare to accelerate the process of genomic interpretation and deliver better patient outcomes.

Prominent players operating in the global AI in genomics market such as Alphabet Inc., Deep Genomics Incorporated, DNAnexus, Inc., Fabric Genomics, Inc., Illumina, Inc., Microsoft Corporation, NVIDIA Corporation, Tempus AI, Inc., Thermo Fisher Scientific Inc., Other Key Players.

The global AI in genomics market has been segmented as follows:

Global AI in Genomics Market Analysis, by Component

  • Software
    • Genomic Data Analysis Software
    • Variant Calling & Interpretation Software
    • Genome Annotation Software
    • Multi-Omics Analysis Software
    • Clinical Decision Support Software
    • Drug Discovery & Biomarker Discovery Software
    • Bioinformatics Workflow Management Software
    • AI Development & Analytics Platforms
    • Others
  • Hardware
    • High-Performance Computing (HPC) Systems
    • GPU & AI Accelerators
    • AI Servers
    • Genomic Sequencing Instruments
    • Data Storage Systems
    • Networking Infrastructure
    • Laboratory Automation Hardware
    • Edge AI Computing Devices
    • Others
  • Services
    • AI Consulting Services
    • Bioinformatics & Genomic Data Analysis Services
    • AI Software Integration & Deployment Services
    • Cloud & Managed AI Services
    • Variant Interpretation Services
    • Regulatory & Compliance Services
    • Technical Support & Maintenance
    • Training & Professional Services
    • Others

Global AI in Genomics Market Analysis, by Technology

  • Machine Learning (ML)
  • Deep Learning
  • Natural Language Processing (NLP)
  • Computer Vision
  • Generative AI
  • Reinforcement Learning
  • Explainable AI (XAI)
  • Predictive Analytics
  • Federated Learning
  • Others

Global AI in Genomics Market Analysis, by Genomics Workflow

  • Genome Sequencing
  • Variant Calling
  • Genome Assembly
  • Gene Expression Analysis
  • Functional Genomics
  • Epigenomics Analysis
  • Multi-Omics Data Integration
  • Genome Annotation
  • Biomarker Discovery
  • Others

Global AI in Genomics Market Analysis, by Deployment Mode

  • Cloud-Based
  • On-Premises
  • Hybrid

Global AI in Genomics Market Analysis, by Data Type

  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • RNA Sequencing
  • Single-Cell Sequencing
  • DNA Methylation Data
  • Proteomics Data
  • Metabolomics Data
  • Microbiome Data
  • Multi-Omics Data

Global AI in Genomics Market Analysis, by Therapeutic Area

  • Oncology
  • Neurology
  • Cardiology
  • Rare Genetic Disorders
  • Infectious Diseases
  • Immunology
  • Metabolic Disorders
  • Reproductive Health
  • Pharmacogenomics
  • Others

Global AI in Genomics Market Analysis, by Application

  • Drug Discovery & Development
  • Precision Medicine
  • Clinical Diagnostics
  • Disease Risk Prediction
  • Rare Disease Analysis
  • Oncology Genomics
  • Population Genomics
  • Agricultural Genomics
  • Infectious Disease Genomics
  • Other Applications

Global AI in Genomics Market Analysis, by End-user

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals
  • Clinical Laboratories
  • Diagnostic Centers
  • Contract Research Organizations (CROs)
  • Government & Public Health Organizations
  • Agricultural & Food Research Organizations
  • Forensic Laboratories
  • Others

Global AI in Genomics Market Analysis, by Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact US

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global AI in Genomics Market Outlook
      • 2.1.1. AI in Genomics Market Size (Value - US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Ecosystem Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. AI-driven genomic data analysis and variant interpretation.
        • 4.1.1.2. Growing adoption of precision medicine and multi-omics integration.
        • 4.1.1.3. Rising demand for AI-enabled drug discovery and biomarker identification.
      • 4.1.2. Restraints
        • 4.1.2.1. Limited availability of high-quality annotated genomic datasets.
        • 4.1.2.2. Data privacy and regulatory compliance challenges.
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Ecosystem Analysis
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global AI in Genomics Market Demand
      • 4.7.1. Historical Market Size – in Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – in Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global AI in Genomics Market Analysis, by Component
    • 6.1. Key Segment Analysis
    • 6.2. AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Component, 2021-2035
      • 6.2.1. Software
        • 6.2.1.1. Genomic Data Analysis Software
        • 6.2.1.2. Variant Calling & Interpretation Software
        • 6.2.1.3. Genome Annotation Software
        • 6.2.1.4. Multi-Omics Analysis Software
        • 6.2.1.5. Clinical Decision Support Software
        • 6.2.1.6. Drug Discovery & Biomarker Discovery Software
        • 6.2.1.7. Bioinformatics Workflow Management Software
        • 6.2.1.8. AI Development & Analytics Platforms
        • 6.2.1.9. Others
      • 6.2.2. Hardware
        • 6.2.2.1. High-Performance Computing (HPC) Systems
        • 6.2.2.2. GPU & AI Accelerators
        • 6.2.2.3. AI Servers
        • 6.2.2.4. Genomic Sequencing Instruments
        • 6.2.2.5. Data Storage Systems
        • 6.2.2.6. Networking Infrastructure
        • 6.2.2.7. Laboratory Automation Hardware
        • 6.2.2.8. Edge AI Computing Devices
        • 6.2.2.9. Others
      • 6.2.3. Services
        • 6.2.3.1. AI Consulting Services
        • 6.2.3.2. Bioinformatics & Genomic Data Analysis Services
        • 6.2.3.3. AI Software Integration & Deployment Services
        • 6.2.3.4. Cloud & Managed AI Services
        • 6.2.3.5. Variant Interpretation Services
        • 6.2.3.6. Regulatory & Compliance Services
        • 6.2.3.7. Technical Support & Maintenance
        • 6.2.3.8. Training & Professional Services
        • 6.2.3.9. Others
  • 7. Global AI in Genomics Market Analysis, by Technology
    • 7.1. Key Segment Analysis
    • 7.2. AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
      • 7.2.1. Machine Learning (ML)
      • 7.2.2. Deep Learning
      • 7.2.3. Natural Language Processing (NLP)
      • 7.2.4. Computer Vision
      • 7.2.5. Generative AI
      • 7.2.6. Reinforcement Learning
      • 7.2.7. Explainable AI (XAI)
      • 7.2.8. Predictive Analytics
      • 7.2.9. Federated Learning
      • 7.2.10. Others
  • 8. Global AI in Genomics Market Analysis, by Genomics Workflow
    • 8.1. Key Segment Analysis
    • 8.2. AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Genomics Workflow, 2021-2035
      • 8.2.1. Genome Sequencing
      • 8.2.2. Variant Calling
      • 8.2.3. Genome Assembly
      • 8.2.4. Gene Expression Analysis
      • 8.2.5. Functional Genomics
      • 8.2.6. Epigenomics Analysis
      • 8.2.7. Multi-Omics Data Integration
      • 8.2.8. Genome Annotation
      • 8.2.9. Biomarker Discovery
      • 8.2.10. Others
  • 9. Global AI in Genomics Market Analysis, by Deployment Mode
    • 9.1. Key Segment Analysis
    • 9.2. AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
      • 9.2.1. Cloud-Based
      • 9.2.2. On-Premises
      • 9.2.3. Hybrid
  • 10. Global AI in Genomics Market Analysis, by Data Type
    • 10.1. Key Segment Analysis
    • 10.2. AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Data Type, 2021-2035
      • 10.2.1. Whole Genome Sequencing (WGS)
      • 10.2.2. Whole Exome Sequencing (WES)
      • 10.2.3. RNA Sequencing
      • 10.2.4. Single-Cell Sequencing
      • 10.2.5. DNA Methylation Data
      • 10.2.6. Proteomics Data
      • 10.2.7. Metabolomics Data
      • 10.2.8. Microbiome Data
      • 10.2.9. Multi-Omics Data
  • 11. Global AI in Genomics Market Analysis, by Therapeutic Area
    • 11.1. Key Segment Analysis
    • 11.2. AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Therapeutic Area, 2021-2035
      • 11.2.1. Oncology
      • 11.2.2. Neurology
      • 11.2.3. Cardiology
      • 11.2.4. Rare Genetic Disorders
      • 11.2.5. Infectious Diseases
      • 11.2.6. Immunology
      • 11.2.7. Metabolic Disorders
      • 11.2.8. Reproductive Health
      • 11.2.9. Pharmacogenomics
      • 11.2.10. Others
  • 12. Global AI in Genomics Market Analysis, by Application
    • 12.1. Key Segment Analysis
    • 12.2. AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
      • 12.2.1. Drug Discovery & Development
      • 12.2.2. Precision Medicine
      • 12.2.3. Clinical Diagnostics
      • 12.2.4. Disease Risk Prediction
      • 12.2.5. Rare Disease Analysis
      • 12.2.6. Oncology Genomics
      • 12.2.7. Population Genomics
      • 12.2.8. Agricultural Genomics
      • 12.2.9. Infectious Disease Genomics
      • 12.2.10. Other Applications
  • 13. Global AI in Genomics Market Analysis, by End-user
    • 13.1. Key Segment Analysis
    • 13.2. AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, by End-user, 2021-2035
      • 13.2.1. Pharmaceutical & Biotechnology Companies
      • 13.2.2. Academic & Research Institutes
      • 13.2.3. Hospitals
      • 13.2.4. Clinical Laboratories
      • 13.2.5. Diagnostic Centers
      • 13.2.6. Contract Research Organizations (CROs)
      • 13.2.7. Government & Public Health Organizations
      • 13.2.8. Agricultural & Food Research Organizations
      • 13.2.9. Forensic Laboratories
      • 13.2.10. Others
  • 14. Global AI in Genomics Market Analysis, by Region
    • 14.1. Key Findings
    • 14.2. AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 14.2.1. North America
      • 14.2.2. Europe
      • 14.2.3. Asia Pacific
      • 14.2.4. Middle East
      • 14.2.5. Africa
      • 14.2.6. South America
  • 15. North America AI in Genomics Market Analysis
    • 15.1. Key Segment Analysis
    • 15.2. Regional Snapshot
    • 15.3. North America AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 15.3.1. Component
      • 15.3.2. Technology
      • 15.3.3. Genomics Workflow
      • 15.3.4. Deployment Mode
      • 15.3.5. Data Type
      • 15.3.6. Therapeutic Area
      • 15.3.7. Application
      • 15.3.8. End User
      • 15.3.9. Country
        • 15.3.9.1. USA
        • 15.3.9.2. Canada
        • 15.3.9.3. Mexico
    • 15.4. USA AI in Genomics Market
      • 15.4.1. Country Segmental Analysis
      • 15.4.2. Component
      • 15.4.3. Technology
      • 15.4.4. Genomics Workflow
      • 15.4.5. Deployment Mode
      • 15.4.6. Data Type
      • 15.4.7. Therapeutic Area
      • 15.4.8. Application
      • 15.4.9. End User
    • 15.5. Canada AI in Genomics Market
      • 15.5.1. Country Segmental Analysis
      • 15.5.2. Component
      • 15.5.3. Technology
      • 15.5.4. Genomics Workflow
      • 15.5.5. Deployment Mode
      • 15.5.6. Data Type
      • 15.5.7. Therapeutic Area
      • 15.5.8. Application
      • 15.5.9. End User
    • 15.6. Mexico AI in Genomics Market
      • 15.6.1. Country Segmental Analysis
      • 15.6.2. Component
      • 15.6.3. Technology
      • 15.6.4. Genomics Workflow
      • 15.6.5. Deployment Mode
      • 15.6.6. Data Type
      • 15.6.7. Therapeutic Area
      • 15.6.8. Application
      • 15.6.9. End User
  • 16. Europe AI in Genomics Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. Europe AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Component
      • 16.3.2. Technology
      • 16.3.3. Genomics Workflow
      • 16.3.4. Deployment Mode
      • 16.3.5. Data Type
      • 16.3.6. Therapeutic Area
      • 16.3.7. Application
      • 16.3.8. End User
      • 16.3.9. Country
        • 16.3.9.1. Germany
        • 16.3.9.2. United Kingdom
        • 16.3.9.3. France
        • 16.3.9.4. Italy
        • 16.3.9.5. Spain
        • 16.3.9.6. Netherlands
        • 16.3.9.7. Nordic Countries
        • 16.3.9.8. Poland
        • 16.3.9.9. Russia & CIS
        • 16.3.9.10. Rest of Europe
    • 16.4. Germany AI in Genomics Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Component
      • 16.4.3. Technology
      • 16.4.4. Genomics Workflow
      • 16.4.5. Deployment Mode
      • 16.4.6. Data Type
      • 16.4.7. Therapeutic Area
      • 16.4.8. Application
      • 16.4.9. End User
    • 16.5. United Kingdom AI in Genomics Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Component
      • 16.5.3. Technology
      • 16.5.4. Genomics Workflow
      • 16.5.5. Deployment Mode
      • 16.5.6. Data Type
      • 16.5.7. Therapeutic Area
      • 16.5.8. Application
      • 16.5.9. End User
    • 16.6. France AI in Genomics Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Component
      • 16.6.3. Technology
      • 16.6.4. Genomics Workflow
      • 16.6.5. Deployment Mode
      • 16.6.6. Data Type
      • 16.6.7. Therapeutic Area
      • 16.6.8. Application
      • 16.6.9. End User
    • 16.7. Italy AI in Genomics Market
      • 16.7.1. Country Segmental Analysis
      • 16.7.2. Component
      • 16.7.3. Technology
      • 16.7.4. Genomics Workflow
      • 16.7.5. Deployment Mode
      • 16.7.6. Data Type
      • 16.7.7. Therapeutic Area
      • 16.7.8. Application
      • 16.7.9. End User
    • 16.8. Spain AI in Genomics Market
      • 16.8.1. Country Segmental Analysis
      • 16.8.2. Component
      • 16.8.3. Technology
      • 16.8.4. Genomics Workflow
      • 16.8.5. Deployment Mode
      • 16.8.6. Data Type
      • 16.8.7. Therapeutic Area
      • 16.8.8. Application
      • 16.8.9. End User
    • 16.9. Netherlands AI in Genomics Market
      • 16.9.1. Country Segmental Analysis
      • 16.9.2. Component
      • 16.9.3. Technology
      • 16.9.4. Genomics Workflow
      • 16.9.5. Deployment Mode
      • 16.9.6. Data Type
      • 16.9.7. Therapeutic Area
      • 16.9.8. Application
      • 16.9.9. End User
    • 16.10. Nordic Countries AI in Genomics Market
      • 16.10.1. Country Segmental Analysis
      • 16.10.2. Component
      • 16.10.3. Technology
      • 16.10.4. Genomics Workflow
      • 16.10.5. Deployment Mode
      • 16.10.6. Data Type
      • 16.10.7. Therapeutic Area
      • 16.10.8. Application
      • 16.10.9. End User
    • 16.11. Poland AI in Genomics Market
      • 16.11.1. Country Segmental Analysis
      • 16.11.2. Component
      • 16.11.3. Technology
      • 16.11.4. Genomics Workflow
      • 16.11.5. Deployment Mode
      • 16.11.6. Data Type
      • 16.11.7. Therapeutic Area
      • 16.11.8. Application
      • 16.11.9. End User
    • 16.12. Russia & CIS AI in Genomics Market
      • 16.12.1. Country Segmental Analysis
      • 16.12.2. Component
      • 16.12.3. Technology
      • 16.12.4. Genomics Workflow
      • 16.12.5. Deployment Mode
      • 16.12.6. Data Type
      • 16.12.7. Therapeutic Area
      • 16.12.8. Application
      • 16.12.9. End User
    • 16.13. Rest of Europe AI in Genomics Market
      • 16.13.1. Country Segmental Analysis
      • 16.13.2. Component
      • 16.13.3. Technology
      • 16.13.4. Genomics Workflow
      • 16.13.5. Deployment Mode
      • 16.13.6. Data Type
      • 16.13.7. Therapeutic Area
      • 16.13.8. Application
      • 16.13.9. End User
  • 17. Asia Pacific AI in Genomics Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Asia Pacific AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Component
      • 17.3.2. Technology
      • 17.3.3. Genomics Workflow
      • 17.3.4. Deployment Mode
      • 17.3.5. Data Type
      • 17.3.6. Therapeutic Area
      • 17.3.7. Application
      • 17.3.8. End User
      • 17.3.9. Country
        • 17.3.9.1. China
        • 17.3.9.2. India
        • 17.3.9.3. Japan
        • 17.3.9.4. South Korea
        • 17.3.9.5. Australia and New Zealand
        • 17.3.9.6. Indonesia
        • 17.3.9.7. Malaysia
        • 17.3.9.8. Thailand
        • 17.3.9.9. Vietnam
        • 17.3.9.10. Rest of Asia Pacific
    • 17.4. China AI in Genomics Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Component
      • 17.4.3. Technology
      • 17.4.4. Genomics Workflow
      • 17.4.5. Deployment Mode
      • 17.4.6. Data Type
      • 17.4.7. Therapeutic Area
      • 17.4.8. Application
      • 17.4.9. End User
    • 17.5. India AI in Genomics Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Component
      • 17.5.3. Technology
      • 17.5.4. Genomics Workflow
      • 17.5.5. Deployment Mode
      • 17.5.6. Data Type
      • 17.5.7. Therapeutic Area
      • 17.5.8. Application
      • 17.5.9. End User
    • 17.6. Japan AI in Genomics Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Component
      • 17.6.3. Technology
      • 17.6.4. Genomics Workflow
      • 17.6.5. Deployment Mode
      • 17.6.6. Data Type
      • 17.6.7. Therapeutic Area
      • 17.6.8. Application
      • 17.6.9. End User
    • 17.7. South Korea AI in Genomics Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Component
      • 17.7.3. Technology
      • 17.7.4. Genomics Workflow
      • 17.7.5. Deployment Mode
      • 17.7.6. Data Type
      • 17.7.7. Therapeutic Area
      • 17.7.8. Application
      • 17.7.9. End User
    • 17.8. Australia and New Zealand AI in Genomics Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Component
      • 17.8.3. Technology
      • 17.8.4. Genomics Workflow
      • 17.8.5. Deployment Mode
      • 17.8.6. Data Type
      • 17.8.7. Therapeutic Area
      • 17.8.8. Application
      • 17.8.9. End User
    • 17.9. Indonesia AI in Genomics Market
      • 17.9.1. Country Segmental Analysis
      • 17.9.2. Component
      • 17.9.3. Technology
      • 17.9.4. Genomics Workflow
      • 17.9.5. Deployment Mode
      • 17.9.6. Data Type
      • 17.9.7. Therapeutic Area
      • 17.9.8. Application
      • 17.9.9. End User
    • 17.10. Malaysia AI in Genomics Market
      • 17.10.1. Country Segmental Analysis
      • 17.10.2. Component
      • 17.10.3. Technology
      • 17.10.4. Genomics Workflow
      • 17.10.5. Deployment Mode
      • 17.10.6. Data Type
      • 17.10.7. Therapeutic Area
      • 17.10.8. Application
      • 17.10.9. End User
    • 17.11. Thailand AI in Genomics Market
      • 17.11.1. Country Segmental Analysis
      • 17.11.2. Component
      • 17.11.3. Technology
      • 17.11.4. Genomics Workflow
      • 17.11.5. Deployment Mode
      • 17.11.6. Data Type
      • 17.11.7. Therapeutic Area
      • 17.11.8. Application
      • 17.11.9. End User
    • 17.12. Vietnam AI in Genomics Market
      • 17.12.1. Country Segmental Analysis
      • 17.12.2. Component
      • 17.12.3. Technology
      • 17.12.4. Genomics Workflow
      • 17.12.5. Deployment Mode
      • 17.12.6. Data Type
      • 17.12.7. Therapeutic Area
      • 17.12.8. Application
      • 17.12.9. End User
    • 17.13. Rest of Asia Pacific AI in Genomics Market
      • 17.13.1. Country Segmental Analysis
      • 17.13.2. Component
      • 17.13.3. Technology
      • 17.13.4. Genomics Workflow
      • 17.13.5. Deployment Mode
      • 17.13.6. Data Type
      • 17.13.7. Therapeutic Area
      • 17.13.8. Application
      • 17.13.9. End User
  • 18. Middle East AI in Genomics Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Middle East AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Component
      • 18.3.2. Technology
      • 18.3.3. Genomics Workflow
      • 18.3.4. Deployment Mode
      • 18.3.5. Data Type
      • 18.3.6. Therapeutic Area
      • 18.3.7. Application
      • 18.3.8. End User
      • 18.3.9. Country
        • 18.3.9.1. Turkey
        • 18.3.9.2. UAE
        • 18.3.9.3. Saudi Arabia
        • 18.3.9.4. Israel
        • 18.3.9.5. Rest of Middle East
    • 18.4. Turkey AI in Genomics Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Component
      • 18.4.3. Technology
      • 18.4.4. Genomics Workflow
      • 18.4.5. Deployment Mode
      • 18.4.6. Data Type
      • 18.4.7. Therapeutic Area
      • 18.4.8. Application
      • 18.4.9. End User
    • 18.5. UAE AI in Genomics Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Component
      • 18.5.3. Technology
      • 18.5.4. Genomics Workflow
      • 18.5.5. Deployment Mode
      • 18.5.6. Data Type
      • 18.5.7. Therapeutic Area
      • 18.5.8. Application
      • 18.5.9. End User
    • 18.6. Saudi Arabia AI in Genomics Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Component
      • 18.6.3. Technology
      • 18.6.4. Genomics Workflow
      • 18.6.5. Deployment Mode
      • 18.6.6. Data Type
      • 18.6.7. Therapeutic Area
      • 18.6.8. Application
      • 18.6.9. End User
    • 18.7. Israel AI in Genomics Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Component
      • 18.7.3. Technology
      • 18.7.4. Genomics Workflow
      • 18.7.5. Deployment Mode
      • 18.7.6. Data Type
      • 18.7.7. Therapeutic Area
      • 18.7.8. Application
      • 18.7.9. End User
    • 18.8. Rest of Middle East AI in Genomics Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Component
      • 18.8.3. Technology
      • 18.8.4. Genomics Workflow
      • 18.8.5. Deployment Mode
      • 18.8.6. Data Type
      • 18.8.7. Therapeutic Area
      • 18.8.8. Application
      • 18.8.9. End User
  • 19. Africa AI in Genomics Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Africa AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Component
      • 19.3.2. Technology
      • 19.3.3. Genomics Workflow
      • 19.3.4. Deployment Mode
      • 19.3.5. Data Type
      • 19.3.6. Therapeutic Area
      • 19.3.7. Application
      • 19.3.8. End User
      • 19.3.9. Country
        • 19.3.9.1. South Africa
        • 19.3.9.2. Egypt
        • 19.3.9.3. Nigeria
        • 19.3.9.4. Algeria
        • 19.3.9.5. Rest of Africa
    • 19.4. South Africa AI in Genomics Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Component
      • 19.4.3. Technology
      • 19.4.4. Genomics Workflow
      • 19.4.5. Deployment Mode
      • 19.4.6. Data Type
      • 19.4.7. Therapeutic Area
      • 19.4.8. Application
      • 19.4.9. End User
    • 19.5. Egypt AI in Genomics Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Component
      • 19.5.3. Technology
      • 19.5.4. Genomics Workflow
      • 19.5.5. Deployment Mode
      • 19.5.6. Data Type
      • 19.5.7. Therapeutic Area
      • 19.5.8. Application
      • 19.5.9. End User
    • 19.6. Nigeria AI in Genomics Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Component
      • 19.6.3. Technology
      • 19.6.4. Genomics Workflow
      • 19.6.5. Deployment Mode
      • 19.6.6. Data Type
      • 19.6.7. Therapeutic Area
      • 19.6.8. Application
      • 19.6.9. End User
    • 19.7. Algeria AI in Genomics Market
      • 19.7.1. Country Segmental Analysis
      • 19.7.2. Component
      • 19.7.3. Technology
      • 19.7.4. Genomics Workflow
      • 19.7.5. Deployment Mode
      • 19.7.6. Data Type
      • 19.7.7. Therapeutic Area
      • 19.7.8. Application
      • 19.7.9. End User
    • 19.8. Rest of Africa AI in Genomics Market
      • 19.8.1. Country Segmental Analysis
      • 19.8.2. Component
      • 19.8.3. Technology
      • 19.8.4. Genomics Workflow
      • 19.8.5. Deployment Mode
      • 19.8.6. Data Type
      • 19.8.7. Therapeutic Area
      • 19.8.8. Application
      • 19.8.9. End User
  • 20. South America AI in Genomics Market Analysis
    • 20.1. Key Segment Analysis
    • 20.2. Regional Snapshot
    • 20.3. South America AI in Genomics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 20.3.1. Component
      • 20.3.2. Technology
      • 20.3.3. Genomics Workflow
      • 20.3.4. Deployment Mode
      • 20.3.5. Data Type
      • 20.3.6. Therapeutic Area
      • 20.3.7. Application
      • 20.3.8. End User
      • 20.3.9. Country
        • 20.3.9.1. Brazil
        • 20.3.9.2. Argentina
        • 20.3.9.3. Rest of South America
    • 20.4. Brazil AI in Genomics Market
      • 20.4.1. Country Segmental Analysis
      • 20.4.2. Component
      • 20.4.3. Technology
      • 20.4.4. Genomics Workflow
      • 20.4.5. Deployment Mode
      • 20.4.6. Data Type
      • 20.4.7. Therapeutic Area
      • 20.4.8. Application
      • 20.4.9. End User
    • 20.5. Argentina AI in Genomics Market
      • 20.5.1. Country Segmental Analysis
      • 20.5.2. Component
      • 20.5.3. Technology
      • 20.5.4. Genomics Workflow
      • 20.5.5. Deployment Mode
      • 20.5.6. Data Type
      • 20.5.7. Therapeutic Area
      • 20.5.8. Application
      • 20.5.9. End User
    • 20.6. Rest of South America AI in Genomics Market
      • 20.6.1. Country Segmental Analysis
      • 20.6.2. Component
      • 20.6.3. Technology
      • 20.6.4. Genomics Workflow
      • 20.6.5. Deployment Mode
      • 20.6.6. Data Type
      • 20.6.7. Therapeutic Area
      • 20.6.8. Application
      • 20.6.9. End User
  • 21. Key Players/ Company Profile
    • 21.1. Alphabet Inc.
      • 21.1.1. Company Details/ Overview
      • 21.1.2. Company Financials
      • 21.1.3. Key Customers and Competitors
      • 21.1.4. Business/ Industry Portfolio
      • 21.1.5. Product Portfolio/ Specification Details
      • 21.1.6. Pricing Data
      • 21.1.7. Strategic Overview
      • 21.1.8. Recent Developments
    • 21.2. Deep Genomics Incorporated
    • 21.3. DNAnexus, Inc.
    • 21.4. Fabric Genomics, Inc.
    • 21.5. Illumina, Inc.
    • 21.6. Microsoft Corporation
    • 21.7. NVIDIA Corporation
    • 21.8. Tempus AI, Inc.
    • 21.9. Thermo Fisher Scientific Inc.
    • 21.10. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation